Growth in the anti-histamine space has been called into question
29/06/20 -"As many people have been either staying indoors or wearing masks outdoors, there has been a reduction in pollen allergies, which in turn has put pressure on sales for Faes’ principal value creator, ..."
Pages
45
Language
English
Published on
29/06/20
You may also be interested by these reports :
25/04/24
Q1 results surpassed expectations, on the back of a strong showing from immunology drug Dupixent, RSV vaccine Beyfortus and the new launches of ...
24/04/24
The Q1 sales met the street’s expectations, although forex, off-patent drugs’ generic/biosimilar erosion and declining COVID-19 sales adversely ...
24/04/24
Ipsen started 2024 on a positive note with sales ahead of the company-compiled consensus. Double-digit growth was led by Neuroscience, Oncology, and ...
23/04/24
The Q1 results came in ahead of the consensus as growth was supported by healthy performances across all the focus areas. Consequently, the ...